Gastrointestinal and Other Cancers Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |
| The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | Placebo, Sulindac 400 MG | NCT04207944 | Duke University | Recruiting |
| Testing Obeticholic Acid for Familial Adenomatous Polyposis | Biopsy, Obeticholic Acid, Placebo Administration | NCT05223036 | National Cancer Institute (NCI) | Recruiting |
| Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis | Atorvastatin Calcium, Biopsy of Colon, Biospecimen Collection, Placebo Administration, Questionnaire Administration | NCT04767984 | National Cancer Institute (NCI) | Recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Placebo Administration, Questionnaire Administration, Simvastatin | NCT02968810 | National Cancer Institute (NCI) | Active, not recruiting |
| Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD... | Biospecimen Collection, Lisinopril, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction, Questionnaire Administration | NCT04550481 | National Cancer Institute (NCI) | Recruiting |
| GCC Agonist Signal in the Small Intestine | Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide | NCT05107219 | National Cancer Institute (NCI) | Recruiting |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment | NCT02273362 | National Cancer Institute (NCI) | Active, not recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | NCT02772003 | National Cancer Institute (NCI) | Active, not recruiting |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis | Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration | NCT03278925 | National Cancer Institute (NCI) | Active, not recruiting |